Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

A review of the haematopoietic stem cell donation experience: is there room for improvement?

Bone Marrow Transplantation volume 49, pages 729–736 (2014)Cite this article

Subjects

Abstract

Donation of haematopoietic stem cells, either through BM or PBSC collection, is a generally safe procedure for healthy donors although adverse reactions are a definite risk. The invaluable source of donation and its central role in transplantation implies that every effort should be made to alleviate possible difficulties the donor encounters. The physical and psychological reactions to donation have been established for some time, but less is known about the factors that are associated with a poorer donation experience. In this article, we provide an overview of the physical and psychological donation experience and focus attention on demographic, physical and psychological factors that may influence this donation experience. Understanding that toxicity profiles vary with certain donor characteristics is crucial as this knowledge could influence practice in numerous ways including the modification of joining and recruitment policies and the improvement of supportive measures and donor follow-up procedures. Although this review deals with both unrelated and related donors (RDs), there is a relative paucity of regulation of RD care and we call for more attention to this area. Owing to the relative rarity of donation in each country, a global effort to collect donor outcome data is needed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303: 1617–1624.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Baldomero H, Gratwohl M, Gratwohl A, Tichelli A, Niederwieser D, Madrigal A et al. The EBMT activity survey 2009: trends over the past 5 years. Bone Marrow Transplant 2011; 46: 485–501.

    Article  CAS  PubMed  Google Scholar 

  3. Pasquini MC, Wang Z Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides. Available at http://www.cibmtr.org2012.

  4. Boo M, van Walraven SM, Chapman J, Lindberg B, Schmidt AH, Shaw BE et al. Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. Blood 2011; 117: 21–25.

    CAS  PubMed  Google Scholar 

  5. Karlsson L, Quinlan D, Guo D, Brown C, Selinger S, Klassen J et al. Mobilized blood cells vs bone marrow harvest: experience compared in 171 donors with particular reference to pain and fatigue. Bone Marrow Transplant 2004; 33: 709–713.

    CAS  PubMed  Google Scholar 

  6. de la Rubia J, de Arriba F, Arbona C, Pascual MJ, Zamora C, Insunza A et al. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematologica 2008; 93: 735–740.

    CAS  PubMed  Google Scholar 

  7. Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM et al. Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. Blood 2013; 121: 197–206.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood 2009; 113: 3604–3611.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Murata M, Harada M, Kato S, Takahashi S, Ogawa H, Okamoto S et al. Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors. Bone Marrow Transplant 1999; 24: 1065–1071.

    Article  CAS  PubMed  Google Scholar 

  10. Chen SH, Yang SH, Chu SC, Su YC, Chang CY, Chiu YW et al. The role of donor characteristics and post-granulocyte colony-stimulating factor white blood cell counts in predicting the adverse events and yields of stem cell mobilization. Int J Hematol 2011; 93: 652–659.

    PubMed  Google Scholar 

  11. Miller JP, Perry EH, Price TH, Bolan CD Jr, Karanes C, Boyd TM et al. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program. Biol Blood Marrow Transplant 2008; 14 (9 Suppl): 29–36.

    PubMed  Google Scholar 

  12. Holig K, Kramer M, Kroschinsky F, Bornhauser M, Mengling T, Schmidt AH et al. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood 2009; 114: 3757–3763.

    PubMed  Google Scholar 

  13. Fortanier C, Kuentz M, Sutton L, Milpied N, Michalet M, Macquart-Moulin G et al. Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: results of a randomised study. Bone Marrow Transplant 2002; 29: 145–149.

    CAS  PubMed  Google Scholar 

  14. Martino M, Console G, Dattola A, Callea I, Messina G, Moscato T et al. Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience. Bone Marrow Transplant 2009; 44: 163–168.

    CAS  PubMed  Google Scholar 

  15. Pamphilon D, Nacheva E, Navarrete C, Madrigal A, Goldman J . The use of granulocyte-colony-stimulating factor in volunteer unrelated hemopoietic stem cell donors. Transfusion 2008; 48: 1495–1501.

    PubMed  Google Scholar 

  16. Hirsch B, Oseth L, Cain M, Trader E, Pulkrabek S, Lindgren B et al. Effects of granulocyte-colony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors. Blood 2011; 118: 2602–2608.

    CAS  PubMed  Google Scholar 

  17. Gandini A, Roata C, Franchini M, Agostini E, Guizzardi E, Pontiero Giacometti P et al. Unrelated allogeneic bone marrow donation: short- and long-term follow-up of 103 consecutive volunteer donors. Bone Marrow Transplant 2001; 28: 369–374.

    CAS  PubMed  Google Scholar 

  18. Machaczka M, Kalaitzakis E, Eleborg L, Ljungman P, Hagglund H . Comparison of general vs regional anaesthesia for BM harvesting: a retrospective study of anaesthesia-related complications. Bone Marrow Transplant 2010; 45: 53–61.

    CAS  PubMed  Google Scholar 

  19. Nishimori M, Yamada Y, Hoshi K, Akiyama Y, Hoshi Y, Morishima Y et al. Health-related quality of life of unrelated bone marrow donors in Japan. Blood 2002; 99: 1995–2001.

    CAS  PubMed  Google Scholar 

  20. Boulton FE, James V . Guidelines for policies on alternatives to allogeneic blood transfusion. 1. Predeposit autologous blood donation and transfusion. Transfus Med 2007; 17: 354–365.

    CAS  PubMed  Google Scholar 

  21. Favre G, Beksac M, Bacigalupo A, Ruutu T, Nagler A, Gluckman E et al. Differences between graft product and donor side effects following bone marrow or stem cell donation. Bone Marrow Transplant 2003; 32: 873–880.

    CAS  PubMed  Google Scholar 

  22. Stroncek DF, Holland PV, Bartch G, Bixby T, Simmons RG, Antin JH et al. Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program. Blood 1993; 81: 1940–1946.

    CAS  PubMed  Google Scholar 

  23. Rowley SD, Donaldson G, Lilleby K, Bensinger WI, Appelbaum FR . Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation. Blood 2001; 97: 2541–2548.

    CAS  PubMed  Google Scholar 

  24. Heldal D, Brinch L, Tjonnfjord G, Solheim BG, Egeland T, Gadeholt G et al. Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints. Bone Marrow Transplant 2002; 29: 479–486.

    CAS  PubMed  Google Scholar 

  25. Bredeson C, Leger C, Couban S, Simpson D, Huebsch L, Walker I et al. An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting. Biol Blood Marrow Transplant 2004; 10: 405–414.

    PubMed  Google Scholar 

  26. Siddiq S, Pamphilon D, Brunskill S, Doree C, Hyde C, Stanworth S . Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors. Cochrane Database Syst Rev 2009; 21: Cd006406.

    Google Scholar 

  27. Pulsipher M Increased risk of severe adverse events after BM vs PBSC donation: Results of a prospective study of 9494 NMDP donors (2004-2009). http://www.worldmarrow.org/fileadmin/Meeting/IDRC_Presentations/2012-IDRC-Sydney/20120504-Pulsipher.pdf2012.

  28. Halter J, Kodera Y, Ispizua AU, Greinix HT, Schmitz N, Favre G et al. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 2009; 94: 94–101.

    PubMed  Google Scholar 

  29. Halter JP, van Walraven SM, Worel N, Bengtsson M, Hagglund H, Nicoloso de Faveri G et al. Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplant 2013; 48: 220–225.

    CAS  PubMed  Google Scholar 

  30. Anderlini P, Champlin RE . Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges. Blood 2008; 111: 1767–1772.

    CAS  PubMed  Google Scholar 

  31. D'Souza A, Jaiyesimi I, Trainor L, Venuturumili P . Granulocyte colony-stimulating factor administration: adverse events. Transfus Med Rev 2008; 22: 280–290.

    PubMed  Google Scholar 

  32. McCullough J, Kahn J, Adamson J, Anderlini P, Benjamin R, Confer D et al. Hematopoietic growth factors—use in normal blood and stem cell donors: clinical and ethical issues. Transfusion 2008; 48: 2008–2025.

    PubMed  Google Scholar 

  33. Kennedy GA, Morton J, Western R, Butler J, Daly J, Durrant S . Impact of stem cell donation modality on normal donor quality of life: a prospective randomized study. Bone Marrow Transplant 2003; 31: 1033–1035.

    CAS  PubMed  Google Scholar 

  34. Confer DL, Shaw BE, Pamphilon DH . WMDA guidelines for subsequent donations following initial BM or PBSCs. Bone Marrow Transplant 2011; 46: 1409–1412.

    CAS  PubMed  Google Scholar 

  35. Leitner GC, Baumgartner K, Kalhs P, Biener D, Greinix HT, Hoecker P et al. Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors: a cross-sectional study. Bone Marrow Transplant 2009; 43: 357–363.

    CAS  PubMed  Google Scholar 

  36. Wiersum-Osselton JC, van Walraven SM, Bank I, Lenselink AM, Fibbe WE, van der Bom JG et al. Clinical outcomes after peripheral blood stem cell donation by related donors: a Dutch single-center cohort study. Transfusion 2013; 53: 96–103.

    PubMed  Google Scholar 

  37. Anderlini P, Rizzo JD, Nugent ML, Schmitz N, Champlin RE, Horowitz MM . Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant 2001; 27: 689–692.

    CAS  PubMed  Google Scholar 

  38. O'Donnell PV, Pedersen TL, Confer DL, Rizzo JD, Pulsipher MA, Stroncek D et al. Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States. Blood 2010; 115: 5097–5101.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Shaw BE . First do no harm. Blood 2010; 115: 4978–4979.

    CAS  PubMed  Google Scholar 

  40. van Walraven SM, Nicoloso-de Faveri G, Axdorph-Nygell UA, Douglas KW, Jones DA, Lee SJ et al. Family donor care management: principles and recommendations. Bone Marrow Transplant 2010; 45: 1269–1273.

    CAS  PubMed  Google Scholar 

  41. Horowitz MM, Confer DL . Evaluation of hematopoietic stem cell donors. Hematol Am Soc Hematol Educ Program 2005; 1: 469–475.

    Google Scholar 

  42. Human Tissue Authority EU Tissue and Cells Directive. Available at http://www.hta.gov.uk/legislationpoliciesandcodesofpractice/legislation/eutissueandcellsdirectives.cfm2007.

  43. Chang G, McGarigle C, Spitzer TR, McAfee SL, Harris F, Piercy K et al. A comparison of related and unrelated marrow donors. Psychosom. Med 1998; 60: 163–167.

    CAS  PubMed  Google Scholar 

  44. Pulsipher MA, Logan BR, shan Y RDSafe: a multi-institutional study of hematopoietic cell transplantation donor safety and quality of life http://www.cibmtr.org/Studies2010.

  45. Petersdorf EW . The World Marrow Donor Association: 20 years of international collaboration for the support of unrelated donor and cord blood hematopoietic cell transplantation. Bone Marrow Transplant 2010; 45: 807–810.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Shaw BE, Ball L, Beksac M, Bengtsson M, Confer D, Diler S et al. Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations. Bone Marrow Transplant 2010; 45: 832–838.

    CAS  PubMed  Google Scholar 

  47. Lown RN, Shaw BE . 'First do no harm': where do we stand on unrelated hematopoietic cell donor safety? Expert Rev Hematol 2012; 5: 249–252.

    CAS  PubMed  Google Scholar 

  48. King RJ, Confer DL, Greinix HT, Halter J, Horowitz M, Schmidt AH et al. Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplant 2011; 46: 10–13.

    CAS  PubMed  Google Scholar 

  49. Switzer GE, Simmons RG, Dew MA . Helping unrelated strangers: physical and psychological reactions to the bone marrow donation process among anonymous donors1. J Appl Soc Psychol 1996; 26: 469–490.

    Google Scholar 

  50. Yuan S, Ziman A, Smeltzer B, Lu Q, Goldfinger D . Moderate and severe adverse events associated with apheresis donations: incidences and risk factors. Transfusion 2010; 50: 478–486.

    PubMed  Google Scholar 

  51. Stroncek DF, Clay ME, Petzoldt ML, Smith J, Jaszcz W, Oldham FB et al. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996; 36: 601–610.

    CAS  PubMed  Google Scholar 

  52. Ruau D, Liu LY, Clark JD, Angst MS, Butte AJ . Sex differences in reported pain across 11 000 patients captured in electronic medical records. J Pain 2012; 13: 228–234.

    PubMed  PubMed Central  Google Scholar 

  53. Taenzer AH, Clark C, Curry CS . Gender affects report of pain and function after arthroscopic anterior cruciate ligament reconstruction. Anesthesiology 2000; 93: 670–675.

    CAS  PubMed  Google Scholar 

  54. Rademaker M . Do women have more adverse drug reactions? Am J Clin Dermatol 2001; 2: 349–351.

    CAS  PubMed  Google Scholar 

  55. Eder AF, Hillyer CD, Dy BA, Notari EPt, Benjamin RJ . Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA 2008; 299: 2279–2286.

    CAS  PubMed  Google Scholar 

  56. Wiltbank TB, Giordano GF, Kamel H, Tomasulo P, Custer B . Faint and prefaint reactions in whole-blood donors: an analysis of predonation measurements and their predictive value. Transfusion 2008; 48: 1799–1808.

    PubMed  Google Scholar 

  57. Amrein K, Valentin A, Lanzer G, Drexler C . Adverse events and safety issues in blood donation-a comprehensive review. Blood Rev 2012; 26: 33–42.

    PubMed  Google Scholar 

  58. Stroncek D, Shawker T, Follmann D, Leitman SF . G-CSF-induced spleen size changes in peripheral blood progenitor cell donors. Transfusion 2003; 43: 609–613.

    CAS  PubMed  Google Scholar 

  59. Platzbecker U, Prange-Krex G, Bornhauser M, Koch R, Soucek S, Aikele P et al. Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion 2001; 41: 184–189.

    CAS  PubMed  Google Scholar 

  60. Spitzer TR, Areman EM, Cirenza E, Yu M, Dickerson S, Kotula PL et al. The impact of harvest center on quality of marrows collected from unrelated donors. J Hematother 1994; 3: 65–70.

    CAS  PubMed  Google Scholar 

  61. Lavi A, Efrat R, Feigin E, Kadari A . Regional versus general anesthesia for bone marrow harvesting. J Clin Anesth 1993; 5: 204–206.

    CAS  PubMed  Google Scholar 

  62. Knudsen LM, Johnsen HE, Gaarsdal E, Jensen L . Spinal versus general anaesthesia for bone marrow harvesting. Bone Marrow Transplant 1995; 15: 486–487.

    CAS  PubMed  Google Scholar 

  63. Burmeister MA, Standl T, Brauer P, Ramsperger K, Kroger N, Zander A et al. Safety and efficacy of spinal vs general anaesthesia in bone marrow harvesting. Bone Marrow Transplant 1998; 21: 1145–1148.

    CAS  PubMed  Google Scholar 

  64. Bosi A, Bartolozzi B . Safety of bone marrow stem cell donation: a review. Transplant Proc 2010; 42: 2192–2194.

    CAS  PubMed  Google Scholar 

  65. Butterworth VA, Simmons RG, Bartsch G, Randall B, Schimmel M, Stroncek DF . Psychosocial effects of unrelated bone marrow donation: experiences of the National Marrow Donor Program. Blood 1993; 81: 1947–1959.

    CAS  PubMed  Google Scholar 

  66. Christopher KA . The experience of donating bone marrow to a relative. Oncol Nurs Forum 2000; 27: 693–700.

    CAS  PubMed  Google Scholar 

  67. Simmons RG, Schimmel M, Butterworth VA . The self-image of unrelated bone marrow donors. J Health Soc Behav 1993; 34: 285–301.

    CAS  PubMed  Google Scholar 

  68. Switzer GE, Goycoolea JM, Dew MA, Graeff EC, Hegland J . Donating stimulated peripheral blood stem cells vs bone marrow: do donors experience the procedures differently? Bone Marrow Transplant 2001; 27: 917–923.

    CAS  PubMed  Google Scholar 

  69. Butterworth VA, Simmons RG, Schimmel M . When altruism fails: reactions of unrelated bone marrow donors when the recipient dies. Omega 1992; 26: 161–173.

    PubMed  Google Scholar 

  70. Chang G, McGarigle C, Koby D, Antin JH . Symptoms of pain and depression in related marrow donors: changes after transplant. Psychosomatics 2003; 44: 59–64.

    PubMed  Google Scholar 

  71. Switzer GE, Myaskovsky L, Goycoolea JM, Dew MA, Confer DL, King R . Factors associated with ambivalence about bone marrow donation among newly recruited unrelated potential donors. Transplantation 2003; 75: 1517–1523.

    PubMed  Google Scholar 

  72. Switzer GE, Dew MA, Butterworth VA, Simmons RG, Schimmel M . Understanding donors' motivations: a study of unrelated bone marrow donors. Soc Sci Med 1997; 45: 137–147.

    CAS  PubMed  Google Scholar 

  73. Switzer GE, Dew MA, Harrington DJ, Crowley-Matoka M, Myaskovsky L, Abress L et al. Ethnic differences in donation-related characteristics among potential hematopoietic stem cell donors. Transplantation 2005; 80: 890–896.

    PubMed  Google Scholar 

  74. Pillay B, Lee SJ, Katona L, De Bono S, Warren N, Fletcher J et al. The psychosocial impact of haematopoietic SCT on sibling donors. Bone Marrow Transplant 2012; 47: 1361–1365.

    CAS  PubMed  Google Scholar 

  75. Ings SJ, Balsa C, Leverett D, Mackinnon S, Linch DC, Watts MJ . Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. Br J Haematol 2006; 134: 517–525.

    PubMed  Google Scholar 

  76. Vasu S, Leitman SF, Tisdale JF, Hsieh MM, Childs RW, Barrett AJ et al. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood 2008; 112: 2092–2100.

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Platzbecker U, Bornhauser M, Zimmer K, Lerche L, Rutt C, Ehninger G et al. Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells. Transfusion 2005; 45: 11–15.

    PubMed  Google Scholar 

  78. Miflin G, Charley C, Stainer C, Anderson S, Hunter A, Russell N . Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy. Br J Haematol 1996; 95: 345–348.

    CAS  PubMed  Google Scholar 

  79. Spierings E, Kim YH, Hendriks M, Borst E, Sergeant R, Canossi A et al. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013; 19: 1244–1253.

    CAS  PubMed  Google Scholar 

  80. Kroger N, Zabelina T, de Wreede L, Berger J, Alchalby H, van Biezen A et al. Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings. Leukemia 2013; 27: 604–609.

    CAS  PubMed  Google Scholar 

  81. Ayuk F, Zabelina T, Wortmann F, Alchalby H, Wolschke C, Lellek H et al. Donor choice according to age for allo-SCT for AML in complete remission. Bone Marrow Transplant 2013; 48: 1028–1032.

    CAS  PubMed  Google Scholar 

  82. Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98: 2043–2051.

    CAS  PubMed  Google Scholar 

  83. Anderlini P, Przepiorka D, Seong C, Smith TL, Huh YO, Lauppe J et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion 1997; 37: 507–512.

    CAS  PubMed  Google Scholar 

  84. Martino M, Callea I, Condemi A, Dattola A, Irrera G, Marcuccio D et al. Predictive factors that affect the mobilization of CD34(+) cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF). J Clin Apher 2006; 21: 169–175.

    PubMed  Google Scholar 

  85. Chern B, McCarthy N, Hutchins C, Durrant ST . Analgesic infiltration at the site of bone marrow harvest significantly reduces donor morbidity. Bone Marrow Transplant 1999; 23: 947–949.

    CAS  PubMed  Google Scholar 

  86. Pamphilon D, Siddiq S, Brunskill S, Doree C, Hyde C, Horowitz M et al. Stem cell donation-what advice can be given to the donor? Br J Haematol 2009; 147: 71–76.

    PubMed  PubMed Central  Google Scholar 

  87. Kodera Y, Yamamoto K, Harada M, Morishima Y, Dohy H, Asano S et al. PBSC collection from family donors in Japan: a prospective survey. Bone Marrow Transplant 2014; 49: 195–200.

    CAS  PubMed  Google Scholar 

  88. Engelhardt M, Bertz H, Afting M, Waller CF, Finke J . High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection. J Clin Oncol 1999; 17: 2160–2172.

    CAS  PubMed  Google Scholar 

  89. Wolcott DL, Wellisch DK, Fawzy FI, Landsverk J . Psychological adjustment of adult bone marrow transplant donors whose recipient survives. Transplantation 1986; 41: 484–488.

    CAS  PubMed  Google Scholar 

  90. Switzer GE, Dew MA, Magistro CA, Goycoolea JM, Twillman RK, Alter C et al. The effects of bereavement on adult sibling bone marrow donors' psychological well-being and reactions to donation. Bone Marrow Transplant 1998; 21: 181–188.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UCL Cancer Institute, London, UK

    A Billen, J A Madrigal & B E Shaw

  2. Anthony Nolan, London, UK

    A Billen, J A Madrigal & B E Shaw

  3. Royal Marsden Hospital, London, UK

    B E Shaw

Authors
  1. A Billen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J A Madrigal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B E Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Billen.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Billen, A., Madrigal, J. & Shaw, B. A review of the haematopoietic stem cell donation experience: is there room for improvement?. Bone Marrow Transplant 49, 729–736 (2014). https://doi.org/10.1038/bmt.2013.227

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2013.227

Keywords

This article is cited by

Search

Advanced search

Quick links